Montai Health

Montai Health, incubated and founded by Flagship Pioneering in 2019, focuses on leveraging known molecules in nature to develop drugs that can treat and prevent a variety of chronic diseases. The company’s current key focus areas are inflammation and autoimmune diseases. Montai's technology platform, CONECTA, comprehensively maps the biological activities of potential drug molecules within various pathological pathways that drive disease. This platform takes advantage of advancements in the digitization of chemistry and biology, integrating powerful computational tools to link chemical structures with biological activity. The convergence of these technologies enables Montai Health to build a robust and unique drug discovery platform aimed at creating safe, effective, and more patient-centered medicines.